Tag Archive: Angela Hartman, Poulvac Procerta HVT-IBD
... Robust challenge studies demonstrate efficacy of new recombinant vector vaccine for IBDVs
Jan 21, 2021Jennifer GrullonComments Off on Robust challenge studies demonstrate efficacy of new recombinant vector vaccine for IBDVs
DISCOVERIES, Issue 12: A new recombinant vector vaccine provides early protection against variant, classic and very virulent infectious bursal disease viruses, robust challenge studies demonstrate.